Decoding human fetal liver haematopoiesis.

Dorin-Mirel Popescu, Rachel A Botting, Emily Stephenson, Kile Green, Simone Webb, Laura Jardine, Emily F Calderbank, Krzysztof Polanski, Issac Goh, Mirjana Efremova, Meghan Acres, Daniel Maunder, Peter Vegh, Yorick Gitton, Jong-Eun Park, Roser Vento-Tormo, Zhichao Miao, David Dixon, Rachel Rowell, David McDonald, James Fletcher, Elizabeth Poyner, Gary Reynolds, Michael Mather, Corina Moldovan, Lira Mamanova, Frankie Greig, Matthew D Young, Kerstin B Meyer, Steven Lisgo, Jaume Bacardit, Andrew Fuller, Ben Millar, Barbara Innes, Susan Lindsay, Michael J T Stubbington, Monika S Kowalczyk, Bo Li, Orr Ashenberg, Marcin Tabaka, Danielle Dionne, Timothy L Tickle, Michal Slyper, Orit Rozenblatt-Rosen, Andrew Filby, Peter Carey, Alexandra-Chlo�� Villani, Anindita Roy, Aviv Regev, Alain Ch��dotal, Irene Roberts, Berthold G��ttgens, Sam Behjati, Elisa Laurenti, Sarah A Teichmann, Muzlifah Haniffa
Author Information
  1. Dorin-Mirel Popescu: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  2. Rachel A Botting: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  3. Emily Stephenson: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  4. Kile Green: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  5. Simone Webb: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  6. Laura Jardine: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  7. Emily F Calderbank: Department of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  8. Krzysztof Polanski: Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
  9. Issac Goh: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  10. Mirjana Efremova: Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
  11. Meghan Acres: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  12. Daniel Maunder: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  13. Peter Vegh: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  14. Yorick Gitton: Sorbonne Universit��, INSERM, CNRS, Institut de la Vision, Paris, France.
  15. Jong-Eun Park: Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
  16. Roser Vento-Tormo: Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
  17. Zhichao Miao: Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
  18. David Dixon: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  19. Rachel Rowell: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  20. David McDonald: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  21. James Fletcher: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  22. Elizabeth Poyner: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  23. Gary Reynolds: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  24. Michael Mather: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  25. Corina Moldovan: Department of Pathology, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  26. Lira Mamanova: Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
  27. Frankie Greig: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  28. Matthew D Young: Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
  29. Kerstin B Meyer: Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
  30. Steven Lisgo: Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
  31. Jaume Bacardit: School of Computing, Newcastle University, Newcastle upon Tyne, UK.
  32. Andrew Fuller: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  33. Ben Millar: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  34. Barbara Innes: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  35. Susan Lindsay: Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
  36. Michael J T Stubbington: Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
  37. Monika S Kowalczyk: Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  38. Bo Li: Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  39. Orr Ashenberg: Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  40. Marcin Tabaka: Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  41. Danielle Dionne: Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  42. Timothy L Tickle: Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  43. Michal Slyper: Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  44. Orit Rozenblatt-Rosen: Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  45. Andrew Filby: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  46. Peter Carey: Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  47. Alexandra-Chlo�� Villani: Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA.
  48. Anindita Roy: Department of Paediatrics, University of Oxford, Oxford, UK.
  49. Aviv Regev: Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  50. Alain Ch��dotal: Sorbonne Universit��, INSERM, CNRS, Institut de la Vision, Paris, France.
  51. Irene Roberts: Department of Paediatrics, University of Oxford, Oxford, UK.
  52. Berthold G��ttgens: Department of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  53. Sam Behjati: Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK. sb31@sanger.ac.uk.
  54. Elisa Laurenti: Department of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. el422@cam.ac.uk.
  55. Sarah A Teichmann: Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK. st9@sanger.ac.uk.
  56. Muzlifah Haniffa: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK. m.a.haniffa@newcastle.ac.uk.

Abstract

Definitive haematopoiesis in the fetal liver supports self-renewal and differentiation of haematopoietic stem cells and multipotent progenitors (HSC/MPPs) but remains poorly defined in humans. Here, using single-cell transcriptome profiling of approximately 140,000 liver and 74,000 skin, kidney and yolk sac cells, we identify the repertoire of human blood and immune cells during development. We infer differentiation trajectories from HSC/MPPs and evaluate the influence of the tissue microenvironment on blood and immune cell development. We reveal physiological erythropoiesis in fetal skin and the presence of mast cells, natural killer and innate lymphoid cell precursors in the yolk sac. We demonstrate a shift in the haemopoietic composition of fetal liver during gestation away from being predominantly erythroid, accompanied by a parallel change in differentiation potential of HSC/MPPs, which we functionally validate. Our integrated map of fetal liver haematopoiesis provides a blueprint for the study of paediatric blood and immune disorders, and a reference for harnessing the therapeutic potential of HSC/MPPs.

References

  1. Nat Rev Immunol. 2013 Feb;13(2):145-9 [PMID: 23348417]
  2. Clin Immunol. 2017 Oct;183:8-16 [PMID: 28645875]
  3. Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17579-84 [PMID: 23045701]
  4. J Clin Immunol. 2013 May;33(4):711-5 [PMID: 23274800]
  5. Cell Stem Cell. 2015 Jul 2;17(1):35-46 [PMID: 26095048]
  6. Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10302-6 [PMID: 7479772]
  7. Nature. 2015 Oct 1;526(7571):68-74 [PMID: 26432245]
  8. Immunity. 2014 Sep 18;41(3):465-477 [PMID: 25200712]
  9. Nat Commun. 2018 Oct 22;9(1):4383 [PMID: 30348985]
  10. J Exp Med. 1992 Apr 1;175(4):1055-66 [PMID: 1372642]
  11. Blood. 2005 Jun 15;105(12):4715-21 [PMID: 15731180]
  12. Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):373-8 [PMID: 24344308]
  13. Blood. 2019 Aug 1;134(5):480-491 [PMID: 31101625]
  14. J Exp Med. 1993 Dec 1;178(6):1857-66 [PMID: 7504051]
  15. Nature. 2018 Nov;563(7731):347-353 [PMID: 30429548]
  16. Front Immunol. 2017 Sep 20;8:1140 [PMID: 28979259]
  17. Development. 2017 Jul 1;144(13):2323-2337 [PMID: 28676567]
  18. Pediatr Res. 1995 Jun;37(6):806-11 [PMID: 7544455]
  19. J Clin Invest. 2006 Oct;116(10):2808-16 [PMID: 17016561]
  20. Nature. 2019 Feb;566(7745):490-495 [PMID: 30787436]
  21. Science. 2017 Apr 21;356(6335): [PMID: 28428369]
  22. Science. 2016 Sep 9;353(6304): [PMID: 27492475]
  23. Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7629-30 [PMID: 18515423]
  24. J Exp Med. 1995 Apr 1;181(4):1445-58 [PMID: 7699329]
  25. Front Immunol. 2017 Sep 11;8:1119 [PMID: 28951732]
  26. Immunity. 2018 Jun 19;48(6):1160-1171.e5 [PMID: 29858009]
  27. Cell Stem Cell. 2013 Oct 3;13(4):459-70 [PMID: 24094326]
  28. Nat Methods. 2019 Dec;16(12):1289-1296 [PMID: 31740819]
  29. Nat Cell Biol. 2017 Apr;19(4):271-281 [PMID: 28319093]
  30. Blood. 2003 Jun 15;101(12):4748-56 [PMID: 12609849]
  31. J Exp Med. 1994 Jan 1;179(1):279-90 [PMID: 7505801]
  32. Blood. 2015 Apr 16;125(16):2553-7 [PMID: 25755292]
  33. Blood. 2014 May 29;123(22):3466-77 [PMID: 24637361]
  34. Cell Rep. 2016 Aug 2;16(5):1470-1484 [PMID: 27452463]
  35. Nucleic Acids Res. 2019 Jan 8;47(D1):D33-D38 [PMID: 30204897]
  36. Annu Rev Immunol. 2016 May 20;34:93-119 [PMID: 26735697]
  37. Nat Rev Immunol. 2014 Jun;14(6):392-404 [PMID: 24854589]
  38. Cell Stem Cell. 2014 Oct 2;15(4):507-522 [PMID: 25158935]
  39. Nature. 2018 Mar 1;555(7694):54-60 [PMID: 29466336]
  40. Development. 2013 Jun;140(12):2463-7 [PMID: 23715539]
  41. Development. 2015 Sep 15;142(18):3073-6 [PMID: 26395135]
  42. Nat Commun. 2018 Oct 5;9(1):4100 [PMID: 30291229]
  43. Nature. 2017 Jun 29;546(7660):662-666 [PMID: 28614294]
  44. Nat Commun. 2018 Jan 8;9(1):75 [PMID: 29311541]
  45. Transfus Med Hemother. 2017 Jun;44(3):143-150 [PMID: 28626365]
  46. Obstet Gynecol. 1984 Jan;63(1):26-32 [PMID: 6691014]
  47. Cell. 2017 Mar 23;169(1):161-173.e12 [PMID: 28340341]
  48. Nat Immunol. 2018 Jul;19(7):711-722 [PMID: 29925996]
  49. Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50 [PMID: 16199517]
  50. Cell Syst. 2019 Apr 24;8(4):281-291.e9 [PMID: 30954476]
  51. PLoS Med. 2008 Feb;5(2):e35 [PMID: 18271621]
  52. Eur J Immunol. 2017 Aug;47(8):1280-1294 [PMID: 28613415]
  53. Immunity. 2018 Sep 18;49(3):464-476.e4 [PMID: 30193847]
  54. J Clin Immunol. 2018 Jan;38(1):96-128 [PMID: 29226302]
  55. Nat Cell Biol. 2013 Aug;15(8):916-25 [PMID: 23811688]
  56. Front Immunol. 2017 Feb 02;8:73 [PMID: 28210260]
  57. Annu Rev Immunol. 2017 Apr 26;35:469-499 [PMID: 28226228]
  58. Blood. 2016 Mar 10;127(10):1276-86 [PMID: 26773039]
  59. Allergy. 2000 Aug;55(8):688-97 [PMID: 10955693]
  60. Cell Stem Cell. 2016 Aug 4;19(2):266-277 [PMID: 27345837]
  61. Nat Protoc. 2020 Apr;15(4):1484-1506 [PMID: 32103204]

Grants

  1. 110104/Wellcome Trust
  2. 206194/Wellcome Trust
  3. MR/R006237/1/Medical Research Council
  4. MC_PC_16040/Medical Research Council
  5. /Wellcome Trust
  6. MC_UU_00016/13/Medical Research Council
  7. MC_UU_12009/14/Medical Research Council
  8. MC_PC_12009/Medical Research Council
  9. 107931/Wellcome Trust
  10. 211276/Wellcome Trust

MeSH Term

Blood Cells
Cellular Microenvironment
Female
Fetus
Flow Cytometry
Gene Expression Profiling
Hematopoiesis
Humans
Liver
Lymphoid Tissue
Single-Cell Analysis
Stem Cells

Word Cloud

Similar Articles

Cited By